The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...

Antibody–drug conjugates (ADCs) represent one of the most transformative advances in precision oncology over the past two decades and are increasingly positioned to replace conventional chemotherapy ...

Artificial intelligence may help doctors identify serious symptoms in childhood cancer survivors—especially when models are guided with richer prompts.

Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections - but with fewer of the worst side-effects ...

As mRNA jabs move closer to clinical reality, a parallel challenge is emerging: combating the misinformation that could ...

JAMP Pharma Group is a Canadian organization headquartered in Boucherville, in the Greater Montreal area. Having experienced exceptional growth over the last 10 years, JAMP Pharma Group is active in ...

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication ...

Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue.

In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. Subscribe to read this story ...

This week, cancer researchers in New York are one step closer to answering a question that has plagued medical and environmental advocates for decades: What is the role of plastic exposure in the ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...